NLS Pharmaceutics and Kadimastem merger aims to redefine diabetes treatment with multi-target therapies

NLS Pharmaceutics Ltd., a Swiss clinical-stage biopharmaceutical company specialising in therapies for rare and complex central nervous system disorders, is set to merge with Kadimastem ... Read More